Emerging at the UK, retatrutide, a innovative peptide , is sparking considerable interest within the scientific community regarding its ability for weight regulation. This dual GIP and GLP-1 receptor agonist looks to deliver a significant improvement over current therapies, showing promising results in early clinical studies . Researchers believe i